Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways episode artwork

EPISODE · Apr 10, 2026 · 47 MIN

Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways

from Stranded Technologies Podcast · host Infinita City

Sid Sijbrandij is the co-founder of GitLab, one of the world’s largest open-source software companies. But in 2022, his life took a radical turn — he was diagnosed with a rare and aggressive form of cancer.Instead of relying solely on the medical system, Sid took a different approach. He ran every diagnostic imaginable, developed experimental treatments, combined therapies, and ultimately built his own path to survival — even when doctors ran out of options.In this episode, we explore how Sid applied first-principles thinking to medicine, why healthcare systems are fundamentally misaligned with patient incentives, and what the future of personalized treatments could look like. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.infinitacitytimes.com

Episode metadata supplied by the publisher feed · Published Apr 10, 2026

Embed this episode

NOW PLAYING

Ep. 107: Sid Sijbrandij On Beating Cancer with First Principles, n = 1 Personalized Treatments and Special Access Regulatory Pathways

0:00 47:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Stranded Technologies Podcast?

This episode is 47 minutes long.

When was this Stranded Technologies Podcast episode published?

This episode was published on April 10, 2026.

Can I download this Stranded Technologies Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!